[1] Dudney WC, Bodenner D, Stack BC Jr. Parathyroid carcinoma[J]. Otolaryngol Clin North Am, 2010, 43(2):441-453, xi. DOI:10.1016/j.otc.2010.01.011.
[2] Cheon M, Choi JY, Chung JH, et al. Differential findings of tc-99m sestamibi dual-phase parathyroid scintigraphy between benign and malignant parathyroid lesions in patients with primary hyperparathyroidism[J]. Nucl Med Mol Imaging, 2011, 45(4):276-284. DOI:10.1007/s13139-011-0103-y.
[3] Artinyan A, Guzman E, Maghami E, et al. Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization[J]. J Clin Oncol, 2008, 26(24):4039-4041. DOI:10.1200/JCO.2007.15.9038.
[4] Barker HS, Podoll MB, Parker JR, et al. Parathyroid carcinoma with intracranial metastasis at diagnosis in a patient with uncontrolled hypercalcemia[J]. Ann Clin Lab Sci, 2014, 44(4):484-488.
[5] Wei CH, Harari A. Parathyroid carcinoma:update and guidelines for management[J]. Curr Treat Options Oncol, 2012, 13(1):11-23. DOI:10.1007/s11864-011-0171-3.
[6] Mo YF, Zhou J, Bao YQ, et al. Unexpected vertebral metastasis of parathyroid carcinoma[J]. Chin Med J (Engl), 2014, 127(4):800.
[7] Lavely WC, Goetze S, Friedman KP, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single-and dual-phase 99mTc-sestamibi parathyroid scintigraphy[J]. J Nucl Med, 2007, 48(7):1084-1089. DOI:10.2967/jnumed.107.040428.
[8] Greenspan BS, Dillehay G, Intenzo C, et al. SNM practice guideline for parathyroid scintigraphy 4.0[J]. J Nucl Med Technol, 2012, 40(2):111-118. DOI:10.2967/jnmt.112.105122.